Exam 3 Flashcards
(110 cards)
Non Pharm Treatment for schizo
Realistic goals and time course
-social rehabilitation
-psych education
-targeted cognitive therapy
-active community treatment
-therapeutic alliance
-comprehensive care ( psych services and psych med)
General Approach for schizo
-Optimized monotherapy, combo for treatment resistant (clozapine)
-lack of evidence supporting APS polypharmacy
-2nd gen A> 1st gen A
-Substantial risk of suicide or attemp- add clozapine
CATIE trial
-equal efficiency between old and newer antipsych
-newer agents have more permanent SEs and more expensive
Dopamine antagonism effects
-Movement disorders
-Relief of psychosis
-akathisia
-increased prolactin (causes abnormal periods and gynecomastia)
-impulsivity
clozapine class, major se, dosing
-only m4 agonist; 2nd gen antipsych
-se inc hyper-salivation (add scopolamine patch), severe constipation, orthostatsis
-if dose interrupted for more than 48hrs, re-titrate fro starting dose
Clozapine DDI
Antiepileptics dec ANCs
-Lithium helps by inc ANC
Clozapine BBW and REMS
Blood dyscrasis
when to start clozapine
must trail 2 other antipsych b/f (treatment resistant)
-if severe risk of suicide can start clozapine earlier
Clozapine DDI
benzos especially lorazepam IM
Treatment considerations for schizo
-lifelong for most; rare possibility of d/c
-relapse is high
-watch out for incomplete switch/titrations
-recommend IM meds for initial rapid relief of sym
-limit time over MDD to 2-4 weeks and re-eval
who is considered treatment resistant in schizo, include time frame
lack of improvement with at least 2 APS from different classes at optimal dose for 8 weeks
What should you do for treatment augmentation in schizophrenia
-add non-APS agent with mood stabilizers
-ECT and/or ziprasidone with clozapine
1st gen antipsych (6)
ChlorprOmaziNe
Fluphenazine
halopeRidOl
perpheNazine
ThioridAzine
ThIOthixeNe
(confrontation)
1st gen antipsych SE (8)
-Extrapyramidal side effects
-OT prolongation
-Prolactin elevation (w/ longer use)
-Dermatologic
-photosensitivity
-blue gray skin
-orthostatic hypotension
-altered thermoregulation
Antipsych BBW
-dementia related psychosis inc mortality
-pt has dementia and schio is okay to use antipsych but if they experience psychosis d/c
2nd gen antipsych LAI approved for BP
Aripiprazole
Risperdone
2nd gen antipsych SE (8)
-Metabolic syndrome (inc trigycleride, glycemia and weight gain)
-QT prolongatio
-Blood dyscrasia/Neutopenias
-Seizure threshold
-Anticholingeric
-Sedation
-prolactin inc
-Ophthalmic effects
Only approved medication for agitation in alzheimers
Brexpiprazole
2nd gen approved for MMD (4)
All brokies owe five quarters
Aripiprazole
Brexpiprazole
Olanzapine w/ Fluoxetine
Quetiapine
- no LAI
Olanzapine
-Class, se, monitoring
2nd gen antipsych
-se for metabolic risk in younger men
-REMS for post inj delirium with LAI
-dress
-3 hr monitoring (rems)
which drug is in niosh and why
Ziprasidone
-2nd gen
-se : DRESS
-short acting inj requiring reconstitution, tablet
LAI pearls
-good for non-adherent patients
-should stabilize on mono therapy before initiating
-oral challenge with the same drug
-oral overlap needed b/c LAI take a while to show effect
which 2 first gen antipsychs are high potency and consequence
fluphenazine & haloperidol
*inc risk of EPS b/c target D2
which 2 first gen antipsychs are low potency and consequence
Chlorpromazine & thioridazine
*high anticholingeric risk